Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1991-04-18
1992-07-14
Dentz, Bernard
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514312, 546153, 546156, 546183, A61K 3147, A61K 31435, C07D215233, C07D22102
Patent
active
051303183
ABSTRACT:
The invention concerns pharmaceutically useful novel compounds of the formula I, in which R.sup.1, R.sup.2, R.sup.3, R.sup.4, R.sup.5, R.sup.6, R.sup.7, X and Z have the various meanings defined herein, and their non-toxic salts, and pharmaceutical compositions containing them. The novel compounds are of value in treating conditions such as hypertension and congestive heart failure. The invention further concerns processes for the manufacture of the novel compounds and the use of the compounds in medical treatment.
REFERENCES:
patent: 4820843 (1989-04-01), Aldrich et al.
patent: 4880804 (1989-11-01), Carini et al.
G. R. Proctor, et al., J. Chem. Soc., Perkin Trans. I (1972) (14), 1803-8.
Bradbury Robert H.
Ratcliffe Arnold H.
Roberts David A.
Dentz Bernard
Imperial Chemical Industries plc
Jackson Thomas E.
LandOfFree
Angiotensin II antagonizers which are condensed pyridine derivat does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Angiotensin II antagonizers which are condensed pyridine derivat, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Angiotensin II antagonizers which are condensed pyridine derivat will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-334836